Scientific Protocol for the Study of Thyroid Cancer and Other Thyroid Disease in Ukraine Following the Chernobyl Accident
NCT00341094 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 23143
Last updated 2020-10-09
Summary
The nuclear power plant accident at Chornobyl released large quantities of Iodine-131 and other radioisotopes of iodine in the atmosphere, contaminating thousands of square kilometers and exposing millions of people. For this study, a well-defined subset of Ukrainian children aged 0-18 years or in utero at the time of the accident are being identified and examined by well-trained specialists for thyroid disease every two years for at least three cycles. The study is a collaborative effort of research in Ukraine and the United States.
The cohort will include approximately 13,000 persons who were children in 1986, all or most of whom have had their thyroids measured for radioactivity during the weeks immediately following the accident (or whose mothers had measurements taken while the child was in utero). Under a rigid research protocol these subjects will receive diagnostic thyroid examinations, including palpation, ultrasound scanning, thyroid hormone and other laboratory tests, and, if indicated, fine-needle aspiration biopsy. Interview information regarding residential, health, diet and lifestyle history will also be collected. All subjects will be followed for thyroid cancer morbidity and mortality. Thyroid cancers will be confirmed by expert pathology examination of tissue.
In addition to the analysis of thyroid radiation measurements made in May-June, 1986, efforts will be made to reconstruct each person's exposure and to estimate the radiation dose to the thyroid. This will involve the reconstruction of deposition patterns and environmental pathways of the radioiodines, and of the location, dietary characteristics, and lifestyle of each person throughout the exposure period.
The aim of the study is to carry out valid and credible assessments of the early and late morphologic and functional changes in the thyroid glands of persons exposed to radiation from radioactive materials released as a consequence of the Chornobyl nuclear power plant accident. The emphasis is on dose- and time-specific changes.
In the course of the study other possible risk factors will be examined including dietary iodine intake during and after 1986, and the ingestion of potassium iodide for thyroid protection shortly after the accident.
Conditions
- Thyroid Cancer
- Non-Cancer Thyroid Disease
- Non Thyroid Cancer
Sponsors & Collaborators
-
National Cancer Institute (NCI)
lead NIH
Principal Investigators
-
Elizabeth K Cahoon · National Cancer Institute (NCI)
Eligibility
- Min Age
- 18 Years
- Max Age
- 48 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1995-05-01
- Primary Completion
- 2020-10-08
- Completion
- 2020-10-08
Countries
- Ukraine
Study Locations
More Related Trials
-
Studies of Thyroid Abnormalities in Northeastern Kazakhstan Associated With Nuclear Weapons Testing
NCT00341185 ·Status: COMPLETED
-
Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
NCT03647358 ·Status: RECRUITING ·Phase: PHASE1
-
The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
NCT03841617 ·Status: RECRUITING ·Phase: PHASE2
-
Iodine I-131 With or Without Selumetinib in Treating Patients With Recurrent or Metastatic Thyroid Cancer
NCT02393690 ·Status: COMPLETED ·Phase: PHASE2
-
Differentiated Thyroid Cancer Patients Treated With Different Doses of Radioactive Iodine.
NCT06134830 ·Status: NOT_YET_RECRUITING
-
Malignancy Predictors, Bethesda and TI-RADS Scores Correlated With Final Histopathology in Thyroid Diseases
NCT04411290 ·Status: UNKNOWN
-
Iodine I 131 in Treating Patients With Thyroid Cancer
NCT00416949 ·Status: TERMINATED ·Phase: NA
-
Multicenter Study Differentiated Thyroid Carcinoma
NCT00144079 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of I-124 PET/CT for the Diagnosis of Thyroid Cancer
NCT06961084 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical Study of Biokinetic Model of Iodine-131 in Total(Near) Thyroidectomy Patients.
NCT03349294 ·Status: COMPLETED
-
Study of Resistance to Thyroid Hormone After Long-term Exposure in People With Thyroid Cancer
NCT04868045 ·Status: WITHDRAWN ·Phase: PHASE1
-
Effects of Thyroid Hormone Withdrawal on Metabolic Parameters During Radioactive Iodine Therapy in Thyroid Cancer
NCT01744769 ·Status: UNKNOWN
-
Enhancing Radioiodine Incorporation Into Radio Iodine Refractory Thyroid Cancers With MAPK Inhibition
NCT04619316 ·Status: UNKNOWN ·Phase: PHASE2
-
PET Evaluation of Recurrent Differentiated Thyroid Cancer
NCT01641679 ·Status: UNKNOWN
-
Follow up for Patients With Thyroid Cancer Planed for Radioiodine Scan or Treatment
NCT03624751 ·Status: ACTIVE_NOT_RECRUITING
-
Renal Tracer Elimination in Thyroid Cancer Patients Treated With 131-Iodine
NCT02773667 ·Status: COMPLETED
-
Method of Endogenous TSH Stimulation in the Follow-up of Differentiated Thyroid Cancer
NCT01840332 ·Status: COMPLETED ·Phase: NA
-
Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer
NCT00251316 ·Status: COMPLETED ·Phase: PHASE2
-
A Blinded Study Evaluating the Accuracy and Safety of Cyclotron-produced 99mTc in Adult Patients
NCT02514187 ·Status: COMPLETED ·Phase: NA
-
Observational Study on Hypothyroidism in Young Children Following Iodine Contrast Exposure
NCT02766283 ·Status: COMPLETED
-
Lesion Dosimetry With 124-Iodine in Metastatic Thyroid Carcinoma
NCT00673010 ·Status: COMPLETED ·Phase: PHASE1
-
IoN- Is Ablative Radio-iodine Necessary for Low Risk Differentiated Thyroid Cancer Patients
NCT01398085 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2/PHASE3
-
Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up
NCT04290663 ·Status: RECRUITING ·Phase: PHASE3
-
Radiation Exposure and Thyroid Disease in Kazakhstan
NCT00480428 ·Status: COMPLETED
-
Lipid Metabolic Status in Thyroid Carcinoma
NCT01487057 ·Status: COMPLETED